Actively Recruiting
Study on Clostridium Difficile Infection in Infants
Led by First People's Hospital of Hangzhou · Updated on 2024-11-25
150
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
Sponsors
F
First People's Hospital of Hangzhou
Lead Sponsor
W
Westlake University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to investigate the epidemiological characteristics and biomarkers of Clostridium difficile infection in infants . By analyzing historical medical data and patient questionnaires, this retrospective cohort study will identify potential high-risk factors and establish baseline biomarkers to improve diagnosis and treatment for affected patients.
CONDITIONS
Official Title
Study on Clostridium Difficile Infection in Infants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Infants aged 0 to 2 years
- Medical records and patient questionnaires available
- Confirmed Clostridium difficile infection for case group or no infection for control group
You will not qualify if you...
- Infants older than 2 years at diagnosis
- Incomplete medical records or missing key information about infection status, feeding, or antibiotic use
- Presence of severe gastrointestinal conditions that could affect study results
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China, China, 310006
Actively Recruiting
Research Team
L
Li Qian Wang, Master of Medicine
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here